当前位置: X-MOL 学术Expert Rev. Pharmacoecon. Outcomes Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Short-term societal economic burden of first-incident type 2 diabetes-related complications – a nationwide cohort study
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2020-10-29 , DOI: 10.1080/14737167.2020.1837626
Jakob Kjellberg 1 , Christian K. Tikkanen 2 , Malene Bagger 3 , Peter Gæde 4, 5
Affiliation  

ABSTRACT

Background

People with type 2 diabetes are at increased risk of developing diabetes-related complications and the augmented societal costs increase with the severity of complications. The objective was to estimate the short-term attributable societal costs of the first event of specific diabetes-related complications amongst people with type 2 diabetes.

Methods

The study was based on national registry data covering all patients with type 2 diabetes in Denmark. Attributable costs of each event were calculated as the difference between costs of patients with the specific event and costs incurred by their controls. Results were reported for the incidence year and the following two years.

Results

On average, 13,054 patients were identified annually from 2007 to 2013 with one or more of 17 specific first-incident diabetes-related complications. The attributable healthcare costs amounted to 114 million EUR annually in the incidence year alone. Costs were highest in the incidence year but were significantly higher also in the 2nd and 3rd year, driven particularly by increased indirect costs.

Conclusions

Short-term excess costs of treating specific first-incident diabetes-related complications are massive for society. Our study highlights the importance of strengthening primary prevention within type 2 diabetes to minimize the risk of developing costly diabetes-related complications.



中文翻译:

首次发生的2型糖尿病相关并发症的短期社会经济负担–一项全国队列研究

摘要

背景

2型糖尿病患者罹患糖尿病相关并发症的风险增加,并且随着并发症的严重程度增加的社会成本也随之增加。目的是评估2型糖尿病患者首次发生与糖尿病相关的特殊并发症的短期社会成本。

方法

该研究基于覆盖丹麦所有2型糖尿病患者的国家注册数据。每个事件的可归属成本计算为发生特定事件的患者的成本与其对照组所产生的成本之差。报告了发病年份及其后两年的结果。

结果

从2007年到2013年,每年平均鉴定出13054例患者,其中17例特定于糖尿病的首次与糖尿病相关的并发症中有一个或多个。仅在发病年份,每年可归因于医疗的费用就达1.14亿欧元。在间接发生费用增加的推动下,费用在发病年最高,但在第二年第三年也明显更高。

结论

对于社会来说,治疗特定的首次发病的糖尿病相关并发症的短期超额费用是巨大的。我们的研究强调了在2型糖尿病中加强一级预防的重要性,以最大程度地降低发生与糖尿病相关的昂贵并发症的风险。

更新日期:2020-11-18
down
wechat
bug